My Authors
Read all threads
New trial of #hydroxychloroquine for #COVID from China. First thoughts:
1- It's a preprint on medRxiv - this means it has yet to be evaluated by the medical community and the information presented may be erroneous (read with a shaker of salt nearby)…
2- That said, the research protocol was approved by proper Ethics Cmte at Renmin Hospital in Wuhan, research procedures follow Declaration of Helsinki & registered in Chinese Clinical Trial registry #hydrochloroquine #Covid_19

3- Randomized, double-blinded trial (nice!)
4- Added #hydrochloroquine (200mg 2x/day x 5days) to standard therapy (oxygen, antivirals, antibacterials, immunoglobulins +/- steroids)
5- Patients could not have severe/critical #Covid_19 infection; avg age was ~45y.o., even split M/F.
6- Patients had to have chest CT findings of pneumonia (even though "mild" #COVIDー19 infection)
7- Main outcomes: Time to Clinical Recovery (TTCR, mainly improvement in fevers and/or cough) & chest CT changes from Day 1 to Day 6
8- Results: 62 pts in trial
9- Most pts had fever +/- cough at start (~64% & 61%); TTCR was ~1 day shorter in #hydroxychlorquine tx group (~2 vs ~3 days, both listed as statistically significant differences)
10- 81% of HCQ+std tx group had improved pneumonia (on CT scan) vs. 55% of std tx....this was NOT
...statistically significant, though (P=0.25 & 0.30, by my Chi-square & Fisher's exact test computation)
11- No pts who received #hydroxycholoroquine progressed to severe illness vs. 4/31 of std tx...not stat significant, though approaching it (P=0.11 by my Fisher's exact test)
Study Critique:
1- No mention of a pre-study primary outcome, no mention of calc. a proper sample size based on a primary outcome.
2- TTCR was defined as "return of [normal] body temp & cough relief for >72h. But they only mention checking these data for the 6d tx period?
3- Unfortunately, they did not report follow-up PCR tests to see if virus was undetectable in any patients in either group (only clinical/radiographic outcomes)
4- I was a little skeptical of the "statistical significance of the ~1day shorter TTCRs for #Hydroxychloroquine so...
...I made up a hypothetical data set to approximate the mean +/- std dev reported in the study for the two study groups. I ran t-test and non-parametric tests (Mann-Whitney) and I got P values close to what the researchers reported. That was nice...
#COVID19 #Hydroxychloroquine
5- Dose of #Hydroxychloroquine was a bit lower than that used in other trials. Still "worked" tho

All things considered, a decent clinical study. It provides some evidence to support potential benefit in patients with non-severe #COVID19 infection. Have to start somewhere.
Missing some Tweet in this thread? You can try to force a refresh.

Enjoying this thread?

Keep Current with Jeff Aeschlimann

Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

Twitter may remove this content at anytime, convert it as a PDF, save and print for later use!

Try unrolling a thread yourself!

how to unroll video

1) Follow Thread Reader App on Twitter so you can easily mention us!

2) Go to a Twitter thread (series of Tweets by the same owner) and mention us with a keyword "unroll" @threadreaderapp unroll

You can practice here first or read more on our help page!

Follow Us on Twitter!

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just three indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!